Browse By: Country ι Category ι Tag
Home  »  Breast Cancer

Breast Cancer Market Research Reports

More

United States Cardiac Marker Market Report 2017
This report studies sales (consumption) of Cardiac Marker in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Published Date: Jan 2017
Published By: QYResearch

Price: $3800
United States HER2-negative Breast Cancer Market Report 2016
Sales, means the sales volume of HER2-negative Breast Cancer Revenue, means the sales value of HER2-negative Breast Cancer This report studies sales (consumption) of HER2-negative Breast Cancer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering F. Hoffmann-La Roche Novartis Pfizer AbbVie AstraZeneca BioMarin Bristol-Myers Squibb Eisai Eli Lilly Galena Biopharma Incyte Merck Merck Serono Merrimack Nektar Tesaro Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of HER2-negative Breast Cancer in each application, can be divided into Application 1 Applica
Published Date: Sep 2016
Published By: QYResearch

Price: $3800
Global HER2-negative Breast Cancer Market Research Report 2016
Production, means the output of HER2-negative Breast Cancer Revenue, means the sales value of HER2-negative Breast Cancer This report studies HER2-negative Breast Cancer in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering F. Hoffmann-La Roche Novartis Pfizer AbbVie AstraZeneca BioMarin Bristol-Myers Squibb Eisai Eli Lilly Galena Biopharma Incyte Merck Merck Serono Merrimack Nektar Tesaro Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of HER2-negative Breast Cancer in these regions, from 2011 to 2021 (forecast), like North A
Published Date: Sep 2016
Published By: QYResearch

Price: $2900
China HER-2 Positive Breast Cancer Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The HER-2 Positive Breast Cancer market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw mater
Published Date: Jul 2016
Published By: QYResearch

Price: $3200
Europe HER-2 Positive Breast Cancer Industry 2016 Market Research Report
The Europe HER-2 Positive Breast Cancer Industry 2016 Market Research Report is a professional and in-depth study on the current state of the HER-2 Positive Breast Cancer industry.
Published Date: Jul 2016
Published By: QYResearch

Price: $3600
Europe HER-2 Positive Breast Cancer Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The HER-2 Positive Breast Cancer market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw mat
Published Date: Jul 2016
Published By: QYResearch

Price: $3600
Global HER-2 Positive Breast Cancer Consumption 2016 Market Research Report
First, the report provides a basic overview of the HER-2 Positive Breast Cancer industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global HER-2 Positive Breast Cancer market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the HER-2 Positive Breast Cancer market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading indus
Published Date: Jul 2016
Published By: QYResearch

Price: $4000
Global HER-2 Positive Breast Cancer Market Professional Survey Report 2016
Product types including High-Frequency Ophthalmic Diagnostic Equipments High-Frequency Ophthalmic Treatment Instruments The segment applications including Ophthalmic Diagnostic Ophthalmic Treatment Segment regions including (the separated region report can also be offered) EU USA India Japan China The players list (Partly, Players you are interested in can also be added) Roche Genentech ... With no less than 10 top producers. Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc. More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
Published Date: Jul 2016
Published By: QYResearch

Price: $3500
Global HER-2 Positive Breast Cancer Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The HER-2 Positive Breast Cancer market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capaci
Published Date: Jul 2016
Published By: QYResearch

Price: $2800
Quarterly Beverage Tracker Second Quarter 2015: Finland
The Finnish economy is still suffering, but stable prices have seen consumer confidence increase. The Centre Party was elected in April, and pledged to create 200,000 jobs. Soft drinks suffered a dip due to bad weather, an early Easter, the suffering economy, and a rise in sugar prices.
Published Date: Aug 2015
Published By: Canadean

Price: $1545
Global HER-2 Positive Breast Cancer Industry 2015 Market Research Report
The Global HER-2 Positive Breast Cancer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the HER-2 Positive Breast Cancer industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The HER-2 Positive Breast Cancer market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading industry pl
Published Date: Aug 2015
Published By: QYResearch

Price: $2800
Breast Cancer - Pipeline Review, H1 2015
Global Markets Directs, Breast Cancer Pipeline Review, H1 2015, provides an overview of the Breast Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Breast Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inform
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2500
Global Breast Cancer Market Report: 2014 Edition
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer are being female and growing older. In the past few years, the cases of breast cancer have increased tremendously in regions like the US and the Europe. The breast cancer market is driven by various factors like aging population in women, obesity and diabetes, hormonal factors, race and ethnicity and family history. A major trend which will probably remain eternally in the breast cancer treatment industry is the fact that novel and innovative technologies and pharmaceutical molecules are always under development. Challenges associated with br
Published Date: Aug 2014
Published By: Koncept Analytics

Price: $800
Breast Cancer Market Report: 2013 Edition
Riding on the back of evolving technological environment, the global healthcare and pharmaceutical industry is now surmounting new acmes. The growth of the respective sector is further filliped by the increasing number of health related issues surfacing on account of changing lifestyle and incessantly evolving surroundings.  To cater to the necessity of better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved diagnostic technologies and treatment therapies, especially in the field of breast cancer treatment. ‘Cancer’ is the result of any mutation or abnormal changes in the genes which are responsible for regulating the growth of cells and keeping them healthy. The tumor formed
Published Date: Jun 2013
Published By: Koncept Analytics

Price: $800
US Market Changes in the Treatment of Advanced Breast Cancer
A survey with unfolding patient case scenarios was presented to 180 U.S. oncologists who manage patients with metastatic breast cancer for their open-ended responses. In each case, oncologists were asked to respond to questions concerning their choices of treatment regimens, factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients.  This survey was conducted in 2011 and 2012 to determine trends across time and changes in practice patterns in the management of advanced breast cancer.
Published Date: Sep 2012
Published By: Assessment Group

Price: $2900
Avastin (Breast Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Avastin (Breast Cancer) Analysis and Forecasts to 2020 provides Avastin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2007-2020). The report also includes information on Breast Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy a
Published Date: Dec 2011
Published By: GlobalData

Price: $2000
Taxol (Breast Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Taxol (Breast Cancer) Analysis and Forecasts to 2020 provides Taxol sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Breast Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Taxotere (Breast Cancer) Analysis and Forecats to 2017
GlobalDatas pharmaceuticals report, Taxotere (Breast Cancer) Analysis and Forecasts to 2017 provides Taxotere sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2017). The report also includes information on Breast Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Femara (Breast Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Femara (Breast Cancer) Analysis and Forecasts to 2020 provides Femara sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Breast Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Herceptin (Breast Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Herceptin (Breast Cancer) Analysis and Forecasts to 2020 provides Herceptin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Breast Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy a
Published Date: Oct 2011
Published By: GlobalData

Price: $2000

Back To Top